Clinical Study
Indications and Early Outcomes for Total Pancreatectomy at a High-Volume Pancreas Center
Table 2
Characteristics of 63 patients with total pancreatectomy (TP).
| Variable | Tumors | Technical reasons | Troubles | Therapyi-resistant pain |
| Number | 23 | 18 | 15 | 7 | Age (median with interquartile range) | 66 (62–72) | 72.5 (65.5–77.25) | 71 (64–75) | 50 (46–58) |
| Gender | | | | | Male | 10 | 13 | 6 | 5 | Female | 13 | 5 | 9 | 2 |
| Histology | | | | | Cancer | 20 | 15 | 5 | 0 | Benign tumors | 3 | 3 | 3 | 0 | Chronic pancreatitis | 0 | 0 | 6 | 7 | others | 0 | 0 | 1 | 0 |
| Primary TP | 22 | 18 | 3 | 2 | Completion TP | 1 | 0 | 12 | 5 |
| Portal vein/SMV resection | 9 | 0 | 1 | 2 | Splenectomy | 20 | 6 | 14 | 5 | Pylorus-preserving TP | 6 | 17 | 9 | 5 | Multivisceral resection | 4 | 0 | 1 | 3 |
| Enzyme replacement | 2 | 1 | 1 | 7 | Endocrine insufficiency | 3 | 5 | 3 | 6 |
| ASA score | | | | | I | 1 | 0 | 0 | 0 | II | 13 | 5 | 2 | 4 | III | 8 | 12 | 13 | 2 | IV | 1 | 1 | 0 | 1 |
|
|
TP indicates total pancreatectomy; SMV: superior mesenteric vein; ASA: American Society of Anesthesiologists.
|